症状性≤50%颈动脉狭窄与易损斑块特征及可接受的血运重建结局相关:三中心队列研究
这项回顾性多中心病例对照研究纳入800例接受颈动脉血运重建的症状性患者,比较狭窄≤50%(MMDS)与>50%(HDS)两组。MMDS组更常以脑梗死起病,且斑块内出血、溃疡及总体易损斑块特征比例显著更高。两组30天及长期复合结局相似。
要点
- 症状性MMDS患者脑梗死起病比例高于HDS(59.8% vs 48.4%,P=.04)。
- MMDS组斑块内出血(64.0% vs 29.4%)和易损斑块特征(80.0% vs 39.4%)显著更多。
- MMDS与HDS的30天及长期复合结局无显著差异。
核心结论
- 症状性MMDS患者较HDS更常以脑梗死起病,且影像学易损斑块特征比例更高。
- 两组血运重建后30天及长期复合结局相似。
- 磁共振血管壁成像斑块特征可能有助于MMDS患者风险评估。
研究设计与样本
- 回顾性多中心病例对照研究,纳入2016年1月至2026年2月三中心接受颈动脉血运重建的症状性患者共800例。
- MMDS定义为所有术前横断面影像均≤50%狭窄(NASCET标准及ESVS 2023指南),任一影像>50%归为HDS。
- 比较基线特征、症状表型、术前用药、影像易损斑块特征及30天和长期结局。
主要发现
- 800例中MMDS 87例(10.9%),HDS 713例(89.1%)。
- MMDS组男性比例更高(85.1% vs 68.0%,P<.01),脑梗死起病更多(59.8% vs 48.4%,P=.04)。
- MMDS组斑块内出血(64.0% vs 29.4%,P<.01)、溃疡(30.0% vs 13.0%,P<.01)及总体易损斑块特征(80.0% vs 39.4%,P<.01)均更高。
- 30天复合结局(5.7% vs 3.7%,P=.39)及长期(3.3±2.6年)复合结局(17.2% vs 25.0%,P=.11)组间无显著差异。
- 排除50%狭窄的敏感性分析中<50%亚组(n=44)结果与主分析一致。
关键数值与推荐
- MMDS定义为所有术前横断面影像均≤50%狭窄(NASCET标准及ESVS 2023指南)。
- 复合结局包括同侧卒中、短暂性脑缺血发作、心肌梗死和死亡。
临床怎么用
- 对症状性MMDS患者,除狭窄程度外应关注易损斑块特征以辅助风险评估。
- 磁共振血管壁成像斑块特征可能作为MMDS患者评估的补充诊断步骤。
- MMDS患者血运重建后30天及长期结局与HDS相似,但需前瞻性研究确认斑块特征是否应指导治疗选择。
局限性
- 回顾性研究设计。
- 仅纳入接受血运重建的患者,存在选择偏倚。
- MMDS组样本量较小(87例)。
- 需要前瞻性研究验证易损斑块特征是否应指导风险分层和治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current carotid revascularization paradigms are primarily stenosis-based, with optimized medical therapy alone generally recommended for symptomatic patients with (≤50%) mild-to-moderate degree of stenosis (MMDS) and no routine recommendation for revascularization, despite evidence of potentially high-risk plaque features beyond stenosis. We aimed to contrast clinical presentation, prevalence of vulnerable plaque features, and postrevascularization outcomes among symptomatic patients with MMDS and high-degree stenosis (HDS > 50%) across three stroke centers. METHODS: We performed a retrospective multicenter case-control study of symptomatic patients with MMDS vs HDS who underwent carotid revascularization from January 2016 to February 2026. Carotid revascularization procedures included were endarterectomy, transfemoral stenting, and transcarotid revascularization. MMDS was defined as ≤50% stenosis on all available preoperative cross-sectional imaging using North American Symptomatic Carotid Endarterectomy Trial criteria and the European Society for Vascular Surgery 2023 Clinical Practice Guidelines. Patients with any imaging study showing >50% stenosis were classified as HDS. Baseline characteristics, symptom phenotype, preoperative medications, imaging findings, vulnerable plaque features on magnetic resonance angiography with vessel wall imaging, and 30-day and long-term outcomes were compared. Composite outcomes included ipsilateral stroke, transient ischemic attack, myocardial infarction, and death. RESULTS: Among 800 symptomatic patients, 87 (10.9%) had MMDS and 713 (89.1%) had HDS. Patients with MMDS were more frequently male (MMDS: 85.1% vs HDS: 68.0%; P < .01) and more commonly presented with cerebral infarction (MMDS: 59.8% vs HDS: 48.4%; P = .04), whereas transient ischemic attack were trending more frequently in patients with HDS (MMDS: 23.0% vs HDS: 33.5%; P = .05). Neurologic severity was similar by the National Institutes of Health Stroke Scale at admission (MMDS: 3.00 ± 3.54 vs HDS: 4.34 ± 5.78; P = .27), National Institutes of Health Stroke Scale at discharge (MMDS: 1.60 ± 2.20 vs HDS: 2.02 ± 3.64; P = .80), modified Rankin Scale at discharge (MMDS: 0.87 ± 1.25 vs HDS: 0.81 ± 1.09; P = .43), and Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes score (MMDS: 3.83 ± 1.53 vs HDS: 3.47 ± 1.43; P = .31). Patients with MMDS had higher rates of intraplaque hemorrhage (MMDS: 64.0% vs HDS: 29.4%; P < .01), ulceration (MMDS: 30.0% vs HDS: 13.0%; P < .01), and overall vulnerable plaque features other than stenosis (MMDS: 80.0% vs HDS: 39.4%; P < .01). Thirty-day composite outcomes were similar (MMDS: 5.7% vs HDS: 3.7%; P = .39), as were long-term (3.3 ± 2.6 years) composite outcomes (MMDS: 17.2% vs HDS: 25.0%; P = .11). In a sensitivity analysis excluding patients with 50% stenosis, the <50% stenosis subgroup (n = 44) demonstrated findings consistent with the primary analysis, presenting significantly more commonly in males [MDS: 84.1% vs moderate-to-high degree stenosis (MHDS): 69.0%; P = .03], with higher rate of cerebral infarction as their presenting symptom (MDS: 65.9% vs MHDS: 48.7%; P = .03), and vulnerable plaque features (MDS: 84.6% vs MHDS: 42.3%; P <.01), without differences in 30-day or long-term outcomes. CONCLUSIONS: In our series of consecutive revascularized patients with symptomatic carotid disease, compared with HDS, MMDS were more likely to present with cerebral infarction, and had a higher prevalence of vulnerable plaque features on cross-sectional imaging despite lower luminal vessel stenosis. There were similar 30-day and long-term postrevascularization outcomes. In symptomatic patients with MMDS, magnetic resonance angiography with vessel wall imaging plaque characterization may represent an important diagnostic step in the evaluation of patients with higher risk for recurrence of a subsequent neurovascular event. Prospective studies are needed to determine whether vulnerable plaque features, rather than vessel stenosis alone, should guide risk stratification and treatment selection in this population.
引用
- Polania-Sandoval C, Meschia JF, Kumar G, et al. Symptomatic ≤50% carotid artery stenosis is associated with higher rates of vulnerable plaque features and acceptable revascularization outcomes: A three-stroke-center cohort study. J Vasc Surg. 2026. PMID: 42571783. doi:10.1016/j.jvs.2026.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。